iSERA Lifesciences Receives SEBI Warning Letter

iSERA Lifesciences Limited (Formerly Covidh Technologies Limited)

Details of Regulatory Action

• Issuing Authority: Securities and Exchange Board of India (SEBI)
• Nature of Action: Warning Letter
• Date of Receipt: Received via mail on November 6, 2026
• Violations Cited: Failure to submit disclosures required under Regulations 7(3), 13(3), and 47 of the SEBI Listing Regulations
• Financial Impact: The company explicitly states there is "No Impact" on financial, operational or other activities quantifiable in monetary terms

Additional Information

The disclosure was signed by Deepakshi, Company Secretary and Compliance Officer (Membership No. 76335), on behalf of iSERA Lifesciences Limited. The company's CIN is L72200PN1993PLC252720.